Skip to content

Value of ultrasound in hemochromatosis associated arthropathy

Value of ultrasound in hemochromatosis associated arthropathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00005453
Enrollment
105
Registered
2013-11-19
Start date
2012-02-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

haemochromatosis E83.1 M15-M19

Interventions

Group 1: The following patients' groups undergo ultrasound examination of 38 joints: 1) patients with hereditary hemochromatosis associated arthropathy 2) patients with hereditary hemochromatosis wit

Sponsors

Medizinische Universität Graz
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 89 Years

Inclusion criteria

Inclusion criteria: Male or female patient =18 years and <90 years of age HH (with or without arthropathy) as defined below OR hand OA as defined by the American College of Rheumatology (ACR) criteria without evidence of HH

Exclusion criteria

Exclusion criteria: Current treatment with any investigational drug Complete destruction of joints to be investigated by sonography

Design outcomes

Primary

MeasureTime frame
Joint inflammation is detected more often by ultrasound [defined as synovial hypertrophy and/or effusion (SH/E) by B-mode and/or hypervascularisation by Power Doppler (PD)] than by clinical examination (defined as synovial swelling) in patients with HH arthropathy

Secondary

MeasureTime frame
1. Joint inflammation as indicated by ultrasound correlates with pain levels (measured by a visual analogue scale ranging from 0-100mm), the number of tender joints and restriction of functionality as measured by the health assessment questionnaire 2. Ultrasound more frequently detects structural lesions (erosions and/or osteophytes) than conventional x-ray 3. Inflammatory and structural lesions at hand and finger joints detected by sonography in HH arthropathy patients differ from those of HH patients without arthropathy and hand OA patients

Countries

Austria

Contacts

Public ContactChristian Dejaco

Medizinische Universität Graz

christian.dejaco@gmx.net+43-316-385-81144

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026